Other studies also confirmed that altering RCAN1 levels either by overexpression or knock-out approaches resulted in memory deficits and impaired synaptic plasticity, both of which are frequently observed in AD patients (344, 345). This evidence concerns the gene RCAN1 and Alzheimer disease.